Title: Young-Ming Huang: Innovator in Pharmaceutical Composition
Introduction
Young-Ming Huang is a notable inventor based in China, recognized for his contributions to the field of pharmaceuticals. He has focused on developing innovative solutions for preventing and treating diseases associated with amyloid beta peptides. His work is significant in the ongoing battle against neurodegenerative conditions.
Latest Patents
Young-Ming Huang has recently worked on two notable patents. The first patent is titled "Pharmaceutical Composition For Preventing Or Treating Amyloid Beta Peptide-Associated Diseases Or Conditions." This composition contains isoacteoside, which is effective in inhibiting the formation, accumulation, or aggregation of amyloid beta peptides. The weight ratio of isoacteoside to acteoside in this composition ranges from 4:1 to 1:4. The second patent is "Use Of Isoacteoside Or Pharmaceutically Acceptable Salt Thereof." This patent describes the use of isoacteoside or its pharmaceutically acceptable salt as an inhibitor of the production, accumulation, or aggregation of amyloid beta peptides, which is crucial for preventing or treating related diseases or symptoms.
Career Highlights
Young-Ming Huang is currently associated with Sinphar Tian-li Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential impact on treating conditions linked to amyloid beta peptides.
Collaborations
Young-Ming Huang has collaborated with notable colleagues, including Hang-Ching Lin and Muh-Hwan Su. Their combined expertise contributes to the advancement of research in the pharmaceutical field.
Conclusion
Young-Ming Huang is a dedicated inventor whose work in pharmaceutical compositions holds promise for addressing significant health challenges. His innovative approaches to amyloid beta peptide-related diseases reflect his commitment to improving patient outcomes.